Philippe Camus, M.D.

Dijon, France

Both apps are now back!

Back

The Drug-Induced Respiratory Disease Website and App

Aspirin (Salicylate-ASA) - Aspirin containing drugs

Aspirin-exacerbated respiratory disease (AERD; PMID 24961377) is a naturally-occurring state where aspirin and NSAIDs can produce acute exacerbations and asthma attacks. Tests to document AERD at PMID 17521312. For induction of AS tolerance see PMID 12532116, 23861151, 24369807, 24468245.

Chronic or excessive intake of aspirin can produce pulmonary edema and ARDS (PMID 9743184, 21297545 , 27531848)

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

I - Interstitial/parenchymal lung disease

XLI - Pulmonary edema - Acute lung injury - ARDS

XLII - Pulmonary/alveolar./airway hemorrhage/bleeding

XLIII - Airway involvement

XLIV - Central-large-upper airway (incl. pharyngeal-nasal) involvement

XLV - Pleural and/or pericardial involvement

XLVII - Mediastinal involvement

XLIX - Systemic/Distant conditions, syndromes and reactions

L - Miscellaneous

LI - Cardiovascular involvement / toxicity

LVIII - Pathology